CDC identifies more cases of blood clots after J&J vaccine; reaction remains extremely rare

Johnson & Johnson COVID-19 Vaccine
Posted at 3:02 PM, Apr 23, 2021
and last updated 2021-04-23 15:02:19-04

More cases of a rare clotting reaction to the Johnson & Johnson COVID-19 vaccine have been identified since the single-shot dose was paused earlier this month.

During a hearing Friday with a CDC advisory panel about whether the pause should be lifted, a doctor with the CDC said the number of dangerous blood clots associated with the vaccine had increased to 15. Initially, there were 6 reported cases.

The reaction remains extremely rare. The 15 cases of blood clots is among the nearly 8 million Johnson & Johnson COVID-19 vaccine shots given in this country.

Dr. Tom Shimabukuro said of the 15 confirmed blood clots with low platelet counts, 12 of them resulted in a clot in veins near the brain, called “cerebral venous sinus thrombosis.”

All 15 cases occurred in women; most were in their 30s, although the age range of patients was 18 to 59. Three women have died from the blood clots.

Symptoms, including headaches, were reported about 1-2 weeks following vaccination, Shimabukuro told the panel.

“We will certainly continue our enhanced surveillance for this,” Shimabukuro said.

The Advisory Committee on Immunization Practices is a panel made up of experts in immunizations and makes recommendations to the Centers for Disease Control and Prevention about a wide range of vaccines.

Following the FDA and CDC April 13 recommended pause on the Johnson & Johnson vaccine, the committee delayed a decision last week to gather more information about the blood clots and other risks and benefits of the vaccine.

They are meeting Friday to consider lifting the pause on Johnson & Johnson vaccine, and whether certain people should not receive the vaccine.

Download our streaming app on your favorite device.  Click here for more.

Download our streaming app on your favorite device. Click here for more.